Clinical Protocol: Phase I trial to evaluate the safety of H5.020CMV.PDGF-B for the treatment of a diabetic insensate foot ulcer
スポンサーリンク
概要
- 論文の詳細を見る
- 2000-11-01
著者
-
Margolis David
The Departments Of Dermatology And Biostatistics And Epidemiology
-
Margolis David
The Departments Of Biostatistics And Epidemiology University Of Pennsylvania School Of Medicine
-
HERLYN Meenhard
The Wistar Institute
-
Crombleholme Timothy
Department Of Surgery Children's Hospital Of Philadelphia University Of Pennsylvania School Of
関連論文
- Adenoviral-mediated gene transfer in wound healing: acute inflammatory response in human skin in the SCID mouse model
- Thrombospondin Receptor (CD36) Expression of Human Keratinocytes during Wound Healing in a SCID Mouse/Human Skin Repair Model
- Expression of PKC isoforms in human melanocytic cells in situ
- Adenoviral mediated gene transfer of PDGF-B enhances wound healing in type I and type II diabetic wounds
- Interobserver agreement, sensitivity, and specificity of a "healed" chronic wound
- Clinical Protocol: Phase I trial to evaluate the safety of H5.020CMV.PDGF-B for the treatment of a diabetic insensate foot ulcer
- The accuracy of using a wound care specialth clinic database to study diabetic neuropathic foot ulcers
- Mesenchymal hamartoma of the chest wall
- Permissive environment in postnatal wounds induced by adenoviral-mediated overexpression of the anti-inflammatory cytokine interleukin-10 prevents scar formation